Improving Care Quality for Metabolic Dysfunction-associated Steatotic Liver Disease Through a Structured Yogic Intervention: Protocol for a Randomised Controlled Trial

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in the world. It is strongly linked to obesity, high blood pressure, type 2 diabetes and dyslipidaemia. Yoga, which includes asanas, pranayama, shat-karmas and meditation, may offer a holistic approach to improve the liver, metabolism and mental health. Purpose To evaluate the effectiveness of a 60-min yoga module in improving liver health and metabolic parameters in MASLD patients. Methods This open-label, two-arm, randomised controlled trial enrolled 72 adults aged 18–60 years diagnosed with MASLD, who received standard care at a hospital in Dehradun. Participants were randomised equally into a yoga group, which received a 60-min online yoga module 5 days per week for 3 months, or a control group receiving standard treatment alone. Key assessments include ultrasound measurement of liver fat, liver enzymes (serum glutamate pyruvate transaminase [SGPT], serum glutamic-oxaloacetic transaminase [SGOT]), HbA1c, lipid profile, body mass index, blood pressure, mental health and quality of life. Data collection occurred at baseline and 3 months post-intervention. Results The study is designed to assess improvements in hepatic steatosis and metabolic and psychosocial parameters following intervention. Conclusion This trial will provide evidence on the role of yoga as an adjunct therapy in MASLD management.